Phenitab 18, 27, 36 & 54 18 mg, 27 mg, 36 mg & 54 mg Tablet
PDF Leaflet Revision Date: 12 September 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of ADHD in children, adolescents, and adults.
Dosage (summary)
Starting dose: 18 mg once daily for children/adolescents; 18 or 36 mg for adults.
Onset of Action / Duration
Onset: 1-2 hours, Duration: 12 hours
Special Populations
- Elderly
- Children under 6 years
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation due to potential risks.
Key Drug Interactions
- MAO inhibitors
- Antihypertensives
- Serotonergic medicines
Contraindications
- Hypersensitivity to methylphenidate
- Glaucoma
- Severe cardiovascular disorders
Common side effects
- Insomnia
- Anorexia
- Headache
- Anxiety
- Tics
Counselling Points
- Take in the morning
- Do not chew or crush tablets
- Monitor for mood changes
Serious warnings
- Potential for abuse and dependence
- Cardiovascular risks
- Emergence of psychiatric symptoms
Important Disclaimer
The Phenitab 18, 27, 36 & 54 18 mg, 27 mg, 36 mg & 54 mg Tablet professional information leaflet below is the property of Forrester Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
